Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysisLi-Yang Chen, Miguel A Molina-Vila, Sheng-Yuan Ruan, et al.
JTO Clinical and Research Reports|September 30, 2021
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLCBin-Chi Liao, Wei-Hsun Hsu, Jih-Hsiang Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2013
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTzu-Hsiu Tsai, Ching-Yao Yang, Chao-Chi Ho, et al.
Oncotargets and Therapy|June 13, 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Plos One|April 30, 2024
The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2Man-San Zhang, Yi-Chen Yeh, Hsien-Neng Huang, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasisSheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemChing-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinomaChia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, et al.
Cancer Medicine|December 23, 2023
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancerYen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2017
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgeryWen-Chi Yang, Furen Xiao, Jin-Yuan Shih, et al.
Pageof 9